Space GlucoseControl system for blood glucose control in intensive care patients - a European multicentre observational study. Issue 1 (December 2015)

• Record Type: Journal Article
• Authors: Blaha, Jan; Barteczko-Grajek, Barbara; Berezowicz, Pawel; Charvat, Jiri; Chvojka, Jiri; Grau, Teodoro; Holmgren, Jonathan; Jaschinski, Ulrich; Kopecky, Petr; Manak, Jan; Moehl, Mette; Paddle, Jonathan; Pasculli, Marcello; Petersson, Johan; Petros, Sirak; Radrizzani, Danilo; Singh, Vinodkumar; Starkopf, Joel
• Is Part Of: BMC anesthesiology. Volume 16:Issue 1(2016)
• Page Start: 1
• Page End: 10
• Publication Date: 2015-12
• Subjects: Glycaemia control -- Critically ill patients -- Insulin protocol -- Space Glucose Control -- Enhanced Model Predictive Control (eMPC); Anesthetics -- Periodicals; Anesthesia -- Periodicals; Anesthesiology -- Periodicals; 617.9605
• DOI: 10.1186/s12871-016-0175-4
• Languages: English
• ISSNs: 1471-2253

Abstract

Abstract Background Glycaemia control (GC) remains an important therapeutic goal in critically ill patients. The enhanced Model Predictive Control (eMPC) algorithm, which models the behaviour of blood glucose (BG) and insulin sensitivity in individual ICU patients with variable blood samples, is an effective, clinically proven computer based protocol successfully tested at multiple institutions on medical and surgical patients with different nutritional protocols. eMPC has been integrated into the B.Braun Space GlucoseControl system (SGC), which allows direct data communication between pumps and microprocessor. The present study was undertaken to assess the clinical performance and safety of the SGC for glycaemia control in critically ill patients under routine conditions in different ICU settings and with various nutritional protocols. Methods The study endpoints were the percentage of time the BG was within the target range 4.4 – 8.3 mmol.l−1, the frequency of hypoglycaemic episodes, adherence to the advice of the SGC and BG measurement intervals. BG was monitored, and insulin was given as a continuous infusion according to the advice of the SGC. Nutritional management (enteral, parenteral or both) was carried out at the discretion of each centre. Results 17 centres from 9 European countries included a total of 508 patients, the median study time was 2.9 (1.9-6.1) days. The median (IQR) time–in–target was 83.0 (68.7-93.1) % of time with the mean proposed measurement interval 2.0 ± 0.5 hours. 99.6 % of the SGC advices on insulin infusion rate were accepted by the user. Only 4 episodes (0.01 % of all BG measurements) of severe hypoglycaemia <2.2 mmol.l−1 in 4 patients occurred (0.8 %; 95 % CI 0.02-1.6 %). Conclusion Under routine conditions and under different nutritional protocols the Space GlucoseControl system with integrated eMPC algorithm has exhibited its suitability for glycaemia control in critically ill patients. Trial registration ClinicalTrials.govNCT01523665